18 August 2022Regulatory Invitation to Scandion Oncology webcast and conference call August 25, 2022 Download Presentation Webcast Workbook
17 August 2022Regulatory Scandion Oncology extends PANTAX trial due to better-than-expected tolerability of SCO-101 Download Presentation Webcast Workbook
8 August 2022Regulatory Scandion Oncology announces share purchase by Board of Directors Download Presentation Webcast Workbook
26 July 2022Regulatory Scandion Oncology’s rights issue registered with the Danish Business Authority Download Presentation Webcast Workbook
4 July 2022Regulatory Scandion Oncology announces final outcome of its rights issue Download Presentation Webcast Workbook
1 July 2022Regulatory Scandion Oncology announces preliminary outcome of its rights issue Download Presentation Webcast Workbook
16 June 2022Regulatory Subscription period in Scandion Oncology Rights Issue of up to approximately SEK 93.7 million commences Download Presentation Webcast Workbook
15 June 2022Regulatory Scandion Oncology publishes prospectus in connection with the rights issue of up to approximately SEK 93.7 million Download Presentation Webcast Workbook
3 June 2022Regulatory Invitation to Scandion Oncology webcast and conference call June 10, 2022 Download Presentation Webcast Workbook
1 June 2022Regulatory Scandion Oncology resolves on a Rights Issue of approximately SEK 93.7 million Download Presentation Webcast Workbook
25 May 2022Regulatory Scandion Oncology announces change to its Board of Directors Download Presentation Webcast Workbook
19 May 2022Regulatory Scandion Oncology – Interim Report Q1 2022 Download Presentation Webcast Workbook